Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg in adults with overweight or obesity, and the relationship between gastrointestinal adverse events and weight loss
成人超重或肥胖患者每周一次注射2.4毫克司美格鲁肽的胃肠道耐受性,以及胃肠道不良事件与体重减轻之间的关系
期刊:Diabetes Obesity & Metabolism
影响因子:5.7
doi:10.1111/dom.14551
Wharton, Sean; Calanna, Salvatore; Davies, Melanie; Dicker, Dror; Goldman, Bryan; Lingvay, Ildiko; Mosenzon, Ofri; Rubino, Domenica M; Thomsen, Mette; Wadden, Thomas A; Pedersen, Sue D